Figure 2
![Figure 2. Transplantation using donors with KIR B haplotypes improves overall survival. The univariate Kaplan-Meier curves for overall survival (OS) are shown for patients receiving transplants from donors with (KIR B/x; n = 317) or without (KIR A/A; n = 131) KIR B haplotypes. Survival is significantly better if the donor had a KIR B haplotype (31% [95% CI: 26-36] vs 20% [95% CI: 13-27]; P = .007).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/113/3/10.1182_blood-2008-07-171926/5/zh80020929410002.jpeg?Expires=1730499923&Signature=vlXKNpwDFK2SpUI4uvZ~4hK~HleSs5wpc3uNehvhM62r2aTdU8MR6QJnXHSxQ2xczRe6jt02M3hITumqDTIj0eVXES6nKmjZPdtsKLpob3OcJuIQnrm57ZdZyqjsBVlglBM2aYt1cisXDQKnEgrM7EwZXUQc0hYwmYfQVJvljEu~9uhPMmrgsKQh96Q6bwLGCibO1dj18eN0uvbBaPEXb57Y6hd3-HL~Snn1qbAO-p9yIVWJPc3UsUrynARNMdBDbZYwXQHxBblYAsBo4R95BU1mKYg-fQM1-qiw0eimVj7wCdfu~2qdSlHJw3pwr2HCnKsi96exqutbo4F6hePOpg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Transplantation using donors with KIR B haplotypes improves overall survival. The univariate Kaplan-Meier curves for overall survival (OS) are shown for patients receiving transplants from donors with (KIR B/x; n = 317) or without (KIR A/A; n = 131) KIR B haplotypes. Survival is significantly better if the donor had a KIR B haplotype (31% [95% CI: 26-36] vs 20% [95% CI: 13-27]; P = .007).
